ES2431085T8 - Uso de glutamato, derivados o metabolitos de glutamato, análogos de glutamato o mezclas de los mismos para la fabricación de una composición para el tratamiento de osteoporosis - Google Patents

Uso de glutamato, derivados o metabolitos de glutamato, análogos de glutamato o mezclas de los mismos para la fabricación de una composición para el tratamiento de osteoporosis Download PDF

Info

Publication number
ES2431085T8
ES2431085T8 ES02791128.8T ES02791128T ES2431085T8 ES 2431085 T8 ES2431085 T8 ES 2431085T8 ES 02791128 T ES02791128 T ES 02791128T ES 2431085 T8 ES2431085 T8 ES 2431085T8
Authority
ES
Spain
Prior art keywords
glutamate
osteoporosis
metabolites
mixtures
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES02791128.8T
Other languages
English (en)
Other versions
ES2431085T3 (es
Inventor
Tadeusz Studzinski
Jose Luis Valverde Piedra
Stefan Pierzynowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protista Biotechnology AB
ESSENTYS AB
Original Assignee
Protista Biotechnology AB
ESSENTYS AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27354772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2431085(T8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0104385A external-priority patent/SE520842C2/sv
Application filed by Protista Biotechnology AB, ESSENTYS AB filed Critical Protista Biotechnology AB
Application granted granted Critical
Publication of ES2431085T3 publication Critical patent/ES2431085T3/es
Publication of ES2431085T8 publication Critical patent/ES2431085T8/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
ES02791128T 2001-11-23 2002-11-22 Uso de glutamato, derivados o metabolitos de glutamato, análogos de glutamato o mezclas de los mismos para la fabricación de una composición para el tratamiento de osteoporosis Expired - Lifetime ES2431085T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0103932 2001-11-23
SE0103932 2001-11-23
SE0104385A SE520842C2 (sv) 2001-11-23 2001-12-21 Användning av glutamat, glutamatderivat, glutamatmetaboliter eller glutamatanaloger för att framställa en sammansättning för behandling av osteoporos
SE0104385 2001-12-21
SE0201713A SE0201713D0 (sv) 2001-11-23 2002-06-06 New methods and use III
SE0201713 2002-06-06
PCT/SE2002/002123 WO2003043626A1 (en) 2001-11-23 2002-11-22 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis

Publications (2)

Publication Number Publication Date
ES2431085T3 ES2431085T3 (es) 2013-11-25
ES2431085T8 true ES2431085T8 (es) 2014-01-03

Family

ID=27354772

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02791128T Expired - Lifetime ES2431085T3 (es) 2001-11-23 2002-11-22 Uso de glutamato, derivados o metabolitos de glutamato, análogos de glutamato o mezclas de los mismos para la fabricación de una composición para el tratamiento de osteoporosis

Country Status (15)

Country Link
US (2) US8603981B2 (es)
EP (1) EP1446112B1 (es)
JP (1) JP4447913B2 (es)
KR (1) KR100961291B1 (es)
CN (1) CN100531731C (es)
AU (1) AU2002366111B2 (es)
BR (1) BR0214364A (es)
CA (1) CA2467676C (es)
DK (1) DK1446112T3 (es)
ES (1) ES2431085T3 (es)
HK (1) HK1071059A1 (es)
MX (1) MXPA04004904A (es)
PT (1) PT1446112E (es)
SE (1) SE0201713D0 (es)
WO (1) WO2003043626A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005082385A1 (en) 2004-02-26 2005-09-09 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
PL1745791T3 (pl) 2003-05-07 2013-11-29 Osteologix As Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu
MXPA05013901A (es) * 2003-07-01 2006-03-09 Essentys Ab Uso de acido alfa-cetoglutarico para tratamiento de desnutricion o condicion de glucosa alta en plasma.
SE0301947D0 (sv) * 2003-07-01 2003-07-01 Gramineer Internat Ab New method and uses
US7335686B2 (en) * 2003-10-20 2008-02-26 Council Of Scientific And Industrial Research Method and composition for treating osteoporosis
PL368573A1 (en) * 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals
PL370937A1 (pl) * 2004-10-29 2006-05-02 Sgp & Sons Ab Preparat żywieniowy i/lub farmaceutyczny do stosowania w profilaktyce i leczeniu niedoborów wchłaniania mikroelementów z przewodu pokarmowego oraz zastosowanie preparatu farmaceutycznego jako czynnika stymulującego wchłanianie mikroelementów z przewodu pokarmowego do krwi
PL371081A1 (pl) * 2004-11-08 2006-05-15 Sgp & Sons Ab Preparat farmaceutyczny wpływający na procesy wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt oraz zastosowanie preparatu farmaceutycznego w procesie wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt
US20110105617A1 (en) * 2005-01-11 2011-05-05 Sgp & Sons Ab Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof
PL372183A1 (pl) * 2005-01-11 2006-07-24 Sgp & Sons Ab Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego
WO2007058612A1 (en) * 2005-11-15 2007-05-24 Entress Ab Medicament for use in connection with cartilage impairment
SG194028A1 (en) * 2011-04-18 2013-11-29 Nestec Sa Nutritional compositions having alpha-hica and eicosapentaenoic acid
EP2782588B1 (en) * 2011-11-21 2020-04-15 Emmaus Medical, Inc. Methods and compositions for the treatment of diabetes and related symptoms
CN102805857B (zh) * 2012-08-27 2014-07-02 北京紫萌同达科技有限公司 一种复方氨基酸(15)双肽(2)注射液的制备方法
CN105231038A (zh) * 2015-09-23 2016-01-13 华南农业大学 α-酮戊二酸在制备猪饲料添加剂方面的应用
EP3490971A4 (en) * 2016-08-01 2020-02-26 Filament Biosolutions Inc. METHOD FOR TREATING AND PREVENTING SIDE EFFECTS OF A CANCER TREATMENT
CN110935005A (zh) * 2019-11-19 2020-03-31 宁波大学 一种丙谷二肽的新用途
CN111820330A (zh) * 2020-07-17 2020-10-27 禹城保立康生物饲料有限公司 一种提高哺乳仔猪发育的母猪饲料

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668295A (en) * 1985-04-25 1987-05-26 University Of Dayton Surgical cements
US5310768A (en) * 1987-10-29 1994-05-10 Ab Erik Vinnars Method for improving the glutamine content in skeletal muscle and composition therefore
JPH01216924A (ja) 1988-02-24 1989-08-30 Ajinomoto Co Inc 肝障害治療剤
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
JPH04164028A (ja) 1990-02-19 1992-06-09 Miwon Co Ltd グルタミン酸モノナトリウムを主成分とする疲労快復剤およびその使用方法
JP2702322B2 (ja) * 1991-08-08 1998-01-21 フジックス株式会社 活性アミノ酸カルシウム、およびそれを含有する飲料、ならびにその製造方法
JP3551149B2 (ja) * 1992-03-24 2004-08-04 味の素株式会社 易吸収性ミネラル含有組成物及びそれを含有する飲食品
US5646187A (en) * 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
JP2964290B2 (ja) 1992-08-25 1999-10-18 雪印乳業株式会社 ミネラル吸収促進剤
US5380934A (en) 1992-10-29 1995-01-10 Kyowa Hakko Kogyo Co., Ltd. Process for producing alanylgutamine
DE69330595T2 (de) 1992-11-25 2002-05-23 Ajinomoto Co., Inc. Zubereitungen und Nahrungsmittel enthaltend Mineralien und Poly-gamma-Glutaminsäure
US5849695A (en) * 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
SE9303691D0 (sv) 1993-11-09 1993-11-09 Gramineer Ab New beverage
CN1060336C (zh) * 1995-12-05 2001-01-10 孔彦平 一种防治钙质缺损的药物及其制备方法
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
NL1014380C2 (nl) 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.

Also Published As

Publication number Publication date
WO2003043626A1 (en) 2003-05-30
US8603981B2 (en) 2013-12-10
CA2467676A1 (en) 2003-05-30
MXPA04004904A (es) 2005-04-11
KR20050044589A (ko) 2005-05-12
JP4447913B2 (ja) 2010-04-07
ES2431085T3 (es) 2013-11-25
PT1446112E (pt) 2013-10-21
AU2002366111B2 (en) 2007-06-28
EP1446112A1 (en) 2004-08-18
CN1602190A (zh) 2005-03-30
US9233088B2 (en) 2016-01-12
KR100961291B1 (ko) 2010-06-04
CN100531731C (zh) 2009-08-26
US20040259766A1 (en) 2004-12-23
US20140194521A1 (en) 2014-07-10
AU2002366111A1 (en) 2003-06-10
SE0201713D0 (sv) 2002-06-06
BR0214364A (pt) 2004-10-26
CA2467676C (en) 2011-07-12
DK1446112T3 (da) 2013-10-07
AU2002366111B8 (en) 2003-06-10
JP2005518353A (ja) 2005-06-23
HK1071059A1 (en) 2005-07-08
EP1446112B1 (en) 2013-07-17

Similar Documents

Publication Publication Date Title
ES2431085T8 (es) Uso de glutamato, derivados o metabolitos de glutamato, análogos de glutamato o mezclas de los mismos para la fabricación de una composición para el tratamiento de osteoporosis
BR0300500B1 (pt) composiÇço poliolefÍnica, processo para estabilizaÇço de uma poliolefina e uso de uma mistura.
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
BRPI0607762B8 (pt) análogos de glp-1, composição farmacêutica contendo os mesmos e uso de um composto
BR0113494B1 (pt) processo para a preparaÇço de uma formulaÇço sàlida herbicida, e, uso de uma formulaÇço sàlida herbicida.
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0009956B8 (pt) Composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma
CL2004001069A1 (es) Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii.
UY28348A1 (es) Compuestos novedosos
DK1379522T3 (da) Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
AR028313A1 (es) Un procedimiento para la produccion de una composicion desodorante o antitranspirante
NO20044322L (no) Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
DK1453810T3 (da) Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament indeholdende samme
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
NO20034527D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
DK1368358T3 (da) Isoxazolinderivater som antidepressive midler
ITRM20030194A0 (it) Uso di derivati del 7-nitro-2,1,3-benzossadiazolo per la terapia di forme tumorali.
AR028359A1 (es) Composicion para el control de artropodos
DK1406888T3 (da) Substituerede gamma-lactonforbindelser som NMDA-antagonister
NO20034528D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
AR028097A1 (es) Derivados npticamente activos de 2-aminotetralina, procesos para la preparacion de los mismos y uso terapcutico de composiciones farmaccuticas que los contienen
CL2004000856A1 (es) Compuestos derivados 8b-vonil-11b-(alfa-sustituidos)alquil-estra-1,3,5(10)-trienos; composiciones farmaceuticas; compuestos intermediarios; uso para la anticoncepcion, para el tratamiento de carcinomas de ovario y tumores de celulas granulosas.